Business Wire

Survey Says: Project Leaders Need More PMTQ

Share

Project Management Institute (PMI) today released its Pulse of the Profession® report which reveals that organizations wasted almost 12 percent of their investment in project spend last year due to poor performance—a number that’s barely budged over the past five years. As a solution, PMI is calling on project leaders worldwide to evaluate and bolster their Project Management Technology Quotient or PMTQ. PMI developed the tenets of PMTQ by drawing on insights from innovator companies that put a high priority on digital skills acquisition and knowledge coupled with a commitment to a strong project management culture.

PMTQ adds a layer of project management to the concept of technology quotient (TQ), which is defined as a person’s ability to adapt, manage and integrate content advances in technology for a project or organization.

"In jobs of the future, project teams will be more and more reliant on technology as either an enabler or sometimes as a team member," said Murat Bicak, Senior Vice President, Strategy of PMI. "Having a strong PMTQ, and being technologically fluent, will be essential for anyone charged with making strategy reality."

Data from the 2019 Pulse of the Profession, PMI’s annual global survey of project management professionals, were used to identify PMTQ Innovators – organizations that prioritize the development of digital skills for project management – vs. the Laggards.

KEY COMPONENTS OF PMTQ

  • Always-on curiosity: Project managers with a high PMTQ are always looking for what’s next and trying out new project delivery approaches, ideas, perspectives and technology. Pulse data reveals that PMTQ Innovators demonstrate a strong ability to shift their way of getting work done. In fact, 60 percent of organizations indicate using hybrid project management practices, compared to 29 percent of PMTQ Laggards.
  • All-inclusive leadership: Those with a high PMTQ not only effectively manage people, but also technology — as well as people who are managing technology. An impressive 78 percent of PMTQ Innovators prioritize developing project management business skills, including management of people, versus only 5 percent of PMTQ Laggards, according to Pulse data.
  • A futureproof talent pool: PMTQ Innovators recruit and retain project talent with the skills needed for the digital workforce. They identify employees who can keep up with the trends and adapt their abilities accordingly. According to Pulse data, 82 percent of PMTQ Innovators (vs. 9 percent of PMTQ Laggards) prioritize developing project management technical skills and 81 percent provide ongoing project manager training (vs. 34 percent of PMTQ Laggards).

Gaining and maintaining a superior PMTQ requires support from all levels of an organization. While business leaders often express a desire to gain more and more workers with the know-how to utilize technology, there is still a disconnect on how they are willing to achieve it. In fact, Accenture found that while 60 percent of business leaders had increased their AI investments in 2017, only 3 percent said they would invest significantly in training and reskilling programs through 2020.i Organization leaders must recognize the importance of building digital fluency across their organization, so project managers can best deliver on the tasks asked of them.

When business leaders take note and support project managers on their PMTQ quest, our Pulse of the Profession data shows PMTQ Innovator organizations take the lead on project outcomes. Their projects are more likely to meet their original goals and be delivered on time and within budget, while reducing scope creep and outright failure.

This not only means PMTQ Innovators save money and improve stakeholder satisfaction rates, but when projects do fail, the portion of the budget lost is less than the PMTQ Laggards (8.5 percent versus 16.3 percent).

Read more about the PMTQ in the latest Pulse of the Profession Survey, The Future of Work: Leading the Way With PMTQ, at www.PMI.org/Pulse.

About the PMI Pulse of the Profession® Survey

The Pulse of the Profession Survey was conducted online in November to December 2018. The report highlights feedback and insights from 3,133 project management professionals, 441 Project Management Office (PMO) directors, and 368 executive leaders from a range of industries, including information technology, financial services, manufacturing, government, energy, healthcare, construction, and telecom around the globe.

About Project Management Institute (PMI)

Project Management Institute (PMI) is the world's leading association for those who consider project, program or portfolio management their profession. Founded in 1969, PMI delivers value for more than three million professionals working in nearly every country in the world through global advocacy, collaboration, education and research. We advance careers, improve organizational success and further mature the project management profession through globally-recognized standards, certifications, communities, resources, tools, academic research, publications, professional development courses and networking opportunities. As part of the PMI family, ProjectManagement.com creates online global communities that deliver more resources, better tools, larger networks and broader perspectives. Visit us at www.PMI.org, www.projectmanagement.com, www.facebook.com/PMInstitute and on Twitter @PMInstitute.

i Reworking the Revolution, Accenture (2018)

Contact information

Mary Ortega
Public Relations Specialist
Project Management Institute
14 Campus Blvd.
Newtown Square, PA 19073
Phone: +1 610 356 4600 X7030
E-mail: mary.ortega@pmi.org
Website: www.pmi.org

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FDA Approves OTEZLA® (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease19.7.2019 17:59:00 CESTPress release

Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has approved OTEZLA® (apremilast) 30 mg twice daily (BID) for the treatment of adult patients with oral ulcers associated with Behçet’s Disease. OTEZLA, an oral, selective inhibitor of phosphodiesterase 4 (PDE4), is the first and only approved treatment option for oral ulcers associated with Behçet’s Disease, a rare, chronic, multisystem inflammatory disease that is difficult to treat. “Oral ulcers are a recurring and debilitating manifestation that affects nearly everyone living with Behçet’s Disease, and have an important negative impact on the quality of life for these patients,” said Yusuf Yazici, M.D., Clinical Associate Professor, Department of Medicine, New York University Langone Health. “In the clinical trial, OTEZLA demonstrated improvements in measures of oral ulcers at week 12. OTEZLA has the potential to be a needed treatment option for U.S. patients and their physicians, who

Abiraterone Acetate Included in World Health Organisation’s Essential Medicines List for the Treatment of Metastatic Castration-Resistant Prostate Cancer19.7.2019 13:05:00 CESTPress release

The Janssen Pharmaceutical Companies of Johnson & Johnson is delighted with the recent announcement from the World Health Organisation (WHO) to include abiraterone acetate (ZYTIGA ® ) for the treatment of metastatic castration-resistant prostate cancer (mCRPC), in the updated Essential Medicines List, published on 9th July 2019.1,2 The WHO’s Essential Medicines List is a core guidance document that helps countries prioritise critical health products that are recommended to be widely available and affordable throughout health systems.1 “The inclusion of abiraterone acetate in the WHO Essential Medicines List highlights the critical role that this treatment can play in improving the lives of patients living with mCRPC and their families,” said Dr. Joaquín Casariego, Janssen Therapeutic Area Lead Oncology for Europe, Middle East & Africa, Janssen-Cilag S.A. “I am proud that we are working hard to impact survival and quality of life by developing and providing innovative medicines which ar

Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis19.7.2019 12:30:00 CESTPress release

Gilead Sciences, Inc. (NASDAQ: GILD) announced today that it has licensed three preclinical antiviral programs from Novartis, including investigational agents with the potential to treat human rhinovirus, influenza and herpes viruses. Under the agreement, Gilead will acquire exclusive global rights to develop and commercialize novel small molecules against three undisclosed targets. Novartis will receive an upfront payment and is eligible to receive up to an additional $291 million in potential milestone payments upon achievement of certain development and commercial milestones, as well as royalties on annual net sales. “Today’s announcement builds on Gilead’s heritage in antiviral research and development. We look forward to applying this expertise to advance the development of potential new treatments for viruses with limited therapeutic options,” said John McHutchison AO, MD, Gilead’s Chief Scientific Officer and Head of Research and Development. Gilead’s antiviral portfolio include

Schlumberger Announces Second-Quarter 2019 Results19.7.2019 11:00:00 CESTPress release

Schlumberger Limited (NYSE: SLB) today reported results for the second quarter of 2019. (Stated in millions, except per share amounts) Three Months Ended Change Jun. 30, 2019 Mar. 31, 2019 Jun. 30, 2018 Sequential Year-on-year Revenue $8,269 $7,879 $8,303 5% 0% Pretax segment operating income $968 $908 $1,094 7% -12% Pretax segment operating margin 11.7% 11.5% 13.2% 17 bps -148 bps Net income - GAAP basis $492 $421 $430 17% 14% Net income, excluding charges & credits* $492 $421 $594 17% -17% Diluted EPS - GAAP basis $0.35 $0.30 $0.31 17% 13% Diluted EPS, excluding charges & credits* $0.35 $0.30 $0.43 17% -19% North America revenue $2,801 $2,738 $3,139 2% -11% International revenue $5,463 $5,037 $5,065 8% 8% North America revenue, excluding Cameron $2,243 $2,178 $2,546 3% -12% International revenue, excluding Cameron $4,761 $4,469 $4,387 7% 9% *These are non-GAAP financial measures. See section titled "Charges & Credits" for details. Schlumberger Chairman and CEO Paal Kibsgaard commente

Schlumberger Appoints Olivier Le Peuch as CEO19.7.2019 10:46:00 CESTPress release

Schlumberger Limited (NYSE: SLB) announced today that its Board of Directors has appointed Olivier Le Peuch as its Chief Executive Officer and member of the Schlumberger Board, effective August 1, 2019. Mr. Le Peuch succeeds Paal Kibsgaard, who will retire as Chief Executive Officer effective that same date. Also effective August 1, Mr. Kibsgaard will step down as Chairman of the Board and retire as a member of the Board of Directors. Mr. Kibsgaard will retire after more than 22 years of service to the Company, including eight years as CEO and four years as Chairman. Effective the same date, Mark G. Papa, a current non-independent director, will become non-executive Chairman of the Board. Peter Currie will continue to serve as the Board’s Lead Independent Director. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190719005161/en/ Olivier Le Peuch is appointed Chief Executive Officer and a member of the Schlumberger Board, effe

Fluke Corporation Acquires Industrial Reliability Leader PRÜFTECHNIK19.7.2019 10:00:00 CESTPress release

Fluke Corp., the global leader in test and measurement instruments, has acquired Ismaning, Germany-based PRÜFTECHNIK, a market leader in precision laser shaft alignment, condition monitoring, and non-destructive testing. “Fluke’s acquisition of PRÜFTECHNIK reflects the growing importance our customers place on reliability systems to keep their equipment in optimum operating condition,” said Marc Tremblay, president of Fluke Corporation. “This business will help us usher in the next generation of solutions for our industrial customers.” Fluke Corporation For information on Fluke tools and applications, or to find the location of your nearest distributor, contact Fluke Corporation, P.O. Box 9090, Everett, WA USA 98206, call (800) 44-FLUKE (800-443-5853), fax (425) 446-5116, e-mail fluke-info@fluke.com or visit the Fluke Web site at http://www.fluke.com. About Fluke Founded in 1948, Fluke Corporation is the world leader in compact, professional electronic test tools and software for measu